Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 7Menorrhagia 4Myoma 3Myofibroma 2Uterine Neoplasms 1Pelvic Pain 1Patient Satisfaction 1Pain 1Metrorrhagia 1Hemorrhage 1Adenomyosis 1

Interventions

Misoprostol 5Uterine Myomectomy 3Saline Solution 3relugolix 2dienogest 2carbetocin 2Uterine Artery Embolization 2Tranexamic Acid 2Tourniquets 2Lidocaine 2Leuprolide 2Ascorbic Acid 2ulipristal 1telapristone acetate 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tablets 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1Propofol 1Population Groups 1Oxytocin 1Nuclear Receptor Subfamily 4, Group A, Member 2 1Morcellation 1Methylergonovine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Myofibroma × Uterine Artery Embolization × Clear all
NCT03535610 2020-09-04

EMBOSOFT I

Scitech Produtos Medicos SA

Phase NA Completed
32 enrolled

Myofibroma

NCT00995878 2018-01-12

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Mayo Clinic

Phase 4 Completed
56 enrolled

Leiomyoma, Myoma, Pelvic Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡